26 results
DEFM14A
LABP
Landos Biopharma Inc
25 Apr 24
Proxy related to merger
5:07pm
, employment, severance, consulting, or other agreement with any Landos associate; (v) hire or terminate (other than for cause) any Landos associate or (vi … , retention, employment, severance, consulting, or other agreement with any Company Associate; (E) hire or terminate (other than for cause) any Company
PREM14A
LABP
Landos Biopharma Inc
15 Apr 24
Preliminary proxy related to merger
5:18pm
Landos associate; (v) hire or terminate (other than for cause) any Landos associate or (vi) make any determination under any employee plan … ) enter into or amend any change-of-control, retention, employment, severance, consulting, or other agreement with any Company Associate; (E) hire
DEFA14A
LABP
Landos Biopharma Inc
25 Mar 24
Additional proxy soliciting materials
9:19am
agreement with any Company Associate; (E) hire or terminate (other than for cause) any Company Associate or (F) make any determination under any Employee
8-K
EX-2.1
LABP
Landos Biopharma Inc
25 Mar 24
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
8:54am
; (E) hire or terminate (other than for cause) any Company Associate or (F) make any determination under any Employee Plan that is inconsistent
DEF 14A
7milsm1uft614fl7y8
28 Apr 22
Definitive proxy
4:16pm
10-Q
8ma48s5
17 May 21
Quarterly report
7:26am
10-K
pzlzvwfkyunb
31 Mar 21
Annual report
5:03pm
424B4
wars61 k5igtep
4 Feb 21
Prospectus supplement with pricing info
5:02pm
S-1/A
l5aivynk79ed rh764
28 Jan 21
IPO registration (amended)
9:12am